The tally, one vote per house
22 of 25 research houses agree, +18 houses in 30 days. See which houses, free →
Investors are moving out of tech and cyclical shares and into defensive stocks such as staples, utilities, healthcare and dividend payers as growth worries and rising yields weigh on risk appetite. Most of the 25 houses tracking the theme, 22 of them, argue that this rotation will keep defensives outperforming, and the number of houses covering it has grown by 16 over the past 30 days. A minority, one house, cautions that the staples trade looks crowded and could be trimmed, while another flags that defensive gains may be harder to sustain in a range-bound market.
Each house counts once: its newest view on the theme in the last 60 days. The counts are computed, not written by AI; the summary is AI-written from the houses’ views, without names.
Who the houses are
- Banks9
- Asset managers8
- Podcasts5
- Independent research firms3
Types only: names are shown to members. See who said what, free →
Houses discussing it, 12 weeks
Houses with a view in the 60 days to each week’s end. Latest: 25 houses on 3 Nov.
What the theme implies
- US Equities higher
Positioning
Source: CFTC Commitments of Traders; FinChiefs calculations. Report of 27 Oct 2026. Positioning data →
Named in research
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Questions
What is the “Defensive stocks” theme?
Investors rotating into staples, dividend payers and other non-cyclical stocks as growth worries and rising yields weigh on risk appetite keep defensive equities outperforming. It is one of 70 themes FinChiefs counts across published research from banks, asset managers, independent research firms and podcasts.
How many research houses agree?
22 of 25 research houses agree (88%), counting each house's newest view in the last 60 days: 22 agree, 1 is mixed and 2 disagree. That is +18 houses in 30 days. Members see each house by name.
Which instruments do research houses name for this theme?
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Is this investment advice?
No. Themes summarise what research houses argue. FinChiefs takes no view of its own. Instruments shown are the ones research houses name, not selected or endorsed by FinChiefs. Not investment advice. No prices are shown and no instrument pays to appear.
The Daily Digest in your inbox
Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.